Teladoc Health (NYSE:TDOC) Trading Up 7% – Should You Buy?

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) shot up 7% during mid-day trading on Wednesday . The company traded as high as $10.66 and last traded at $11.13. 123,921 shares were traded during trading, a decline of 97% from the average session volume of 3,805,296 shares. The stock had previously closed at $10.40.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Oppenheimer decreased their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. The Goldman Sachs Group started coverage on shares of Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 target price for the company. Royal Bank of Canada increased their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Bank of America lifted their target price on Teladoc Health from $10.50 to $11.50 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Barclays raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and a consensus price target of $11.97.

View Our Latest Research Report on TDOC

Teladoc Health Trading Up 6.9 %

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $10.03 and its two-hundred day moving average is $9.11. The firm has a market capitalization of $2.20 billion, a P/E ratio of -2.23 and a beta of 1.04.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Institutional investors and hedge funds have recently made changes to their positions in the company. PNC Financial Services Group Inc. boosted its position in shares of Teladoc Health by 22.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider’s stock worth $73,000 after buying an additional 1,439 shares during the period. Edgestream Partners L.P. raised its position in shares of Teladoc Health by 0.8% in the 4th quarter. Edgestream Partners L.P. now owns 201,060 shares of the health services provider’s stock valued at $1,828,000 after buying an additional 1,612 shares in the last quarter. Prescott Group Capital Management L.L.C. bought a new position in shares of Teladoc Health in the 4th quarter valued at $818,000. Vestmark Advisory Solutions Inc. bought a new position in shares of Teladoc Health in the fourth quarter worth about $575,000. Finally, Lindbrook Capital LLC grew its stake in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after buying an additional 1,612 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Stories

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.